ID   PI3R4_HUMAN             Reviewed;        1358 AA.
AC   Q99570; Q2TBF4;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-NOV-2010, entry version 94.
DE   RecName: Full=Phosphoinositide 3-kinase regulatory subunit 4;
DE            Short=PI3-kinase regulatory subunit 4;
DE            EC=2.7.11.1;
DE   AltName: Full=PI3-kinase p150 subunit;
DE   AltName: Full=Phosphoinositide 3-kinase adaptor protein;
GN   Name=PIK3R4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 53-63; 333-343;
RP   540-554 AND 786-791, MYRISTOYLATION AT GLY-2, PHOSPHORYLATION,
RP   COFACTOR, TISSUE SPECIFICITY, AND INTERACTION WITH PIK3C3.
RX   MEDLINE=97153028; PubMed=8999962; DOI=10.1074/jbc.272.4.2477;
RA   Panaretou C., Domin J., Cockcroft S., Waterfield M.D.;
RT   "Characterization of p150, an adaptor protein for the human
RT   phosphatidylinositol (PtdIns) 3-kinase. Substrate presentation by
RT   phosphatidylinositol transfer protein to the p150.PtdIns 3-kinase
RT   complex.";
RL   J. Biol. Chem. 272:2477-2485(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-853; SER-865 AND
RP   THR-1316, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-808; SER-813; SER-814;
RP   SER-853; SER-861; SER-865; SER-892; SER-925 AND SER-1079, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-936.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-273; HIS-342; TRP-347; ILE-388;
RP   ASN-393; VAL-699 AND VAL-1043.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [8]
RP   INTERACTION WITH BECN1; KIAA0226; KIAA0831; PIK3C3 AND UVRAG.
RX   PubMed=19270696; DOI=10.1038/ncb1846;
RA   Matsunaga K., Saitoh T., Tabata K., Omori H., Satoh T., Kurotori N.,
RA   Maejima I., Shirahama-Noda K., Ichimura T., Isobe T., Akira S.,
RA   Noda T., Yoshimori T.;
RT   "Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally
RT   regulate autophagy at different stages.";
RL   Nat. Cell Biol. 11:385-396(2009).
CC   -!- FUNCTION: Regulatory subunit of the PI3K complex. May regulate
CC       membrane trafficking late in the endocytic pathway.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Manganese.
CC   -!- SUBUNIT: Heterodimer. This subunit, part of a complex composed of
CC       regulatory and catalytic subunits, associates with the
CC       phosphatidylinositol 3-kinase type 3 (PIK3C3). Forms a complex
CC       with BECN1, PIK3C3 and either UVRAG and KIAA0226/Rubicon, or with
CC       KIAA0831/Barkor. In this complex, presence of UVRAG and
CC       KIAA0831/Barkor are mutually exclusive.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- PTM: Myristoylated.
CC   -!- PTM: Probably autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 3 HEAT repeats.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 7 WD repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y08991; CAA70176.1; -; mRNA.
DR   EMBL; BC110318; AAI10319.1; -; mRNA.
DR   EMBL; BC127106; AAI27107.1; -; mRNA.
DR   IPI; IPI00024006; -.
DR   RefSeq; NP_055417.1; -.
DR   UniGene; Hs.149032; -.
DR   ProteinModelPortal; Q99570; -.
DR   SMR; Q99570; 23-305, 414-441, 589-680.
DR   DIP; DIP-42310N; -.
DR   IntAct; Q99570; 3.
DR   MINT; MINT-1631706; -.
DR   STRING; Q99570; -.
DR   PhosphoSite; Q99570; -.
DR   PeptideAtlas; Q99570; -.
DR   PRIDE; Q99570; -.
DR   Ensembl; ENST00000356763; ENSP00000349205; ENSG00000196455.
DR   GeneID; 30849; -.
DR   KEGG; hsa:30849; -.
DR   UCSC; uc003enj.1; human.
DR   CTD; 30849; -.
DR   GeneCards; GC03M130397; -.
DR   H-InvDB; HIX0003676; -.
DR   HGNC; HGNC:8982; PIK3R4.
DR   HPA; HPA036032; -.
DR   MIM; 602610; gene.
DR   PharmGKB; PA33315; -.
DR   HOGENOM; HBG315087; -.
DR   HOVERGEN; HBG079542; -.
DR   InParanoid; Q99570; -.
DR   OMA; HFNSGAQ; -.
DR   OrthoDB; EOG9H48PV; -.
DR   PhylomeDB; Q99570; -.
DR   BioCyc; MetaCyc:ENSG00000114679-MONOMER; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   Reactome; REACT_9470; Signaling by FGFR.
DR   NextBio; 52984; -.
DR   ArrayExpress; Q99570; -.
DR   Bgee; Q99570; -.
DR   CleanEx; HS_PIK3R4; -.
DR   Genevestigator; Q99570; -.
DR   GermOnline; ENSG00000196455; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; NAS:UniProtKB.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000357; HEAT.
DR   InterPro; IPR021133; HEAT_type_2.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR011046; WD40_repeat-like_dom.
DR   InterPro; IPR019782; WD40_repeat_2.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR019781; WD40_repeat_sg.
DR   Gene3D; G3DSA:1.25.10.10; ARM-like; 1.
DR   Gene3D; G3DSA:2.130.10.10; WD40/YVTN_repeat-like; 2.
DR   Pfam; PF02985; HEAT; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00400; WD40; 3.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50978; WD40_like; 1.
DR   PROSITE; PS50077; HEAT_REPEAT; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 2.
DR   PROSITE; PS50082; WD_REPEATS_2; 2.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Direct protein sequencing; Kinase;
KW   Lipoprotein; Myristate; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Repeat; Serine/threonine-protein kinase; Transferase;
KW   WD repeat.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2   1358       Phosphoinositide 3-kinase regulatory
FT                                subunit 4.
FT                                /FTId=PRO_0000086524.
FT   DOMAIN       26    324       Protein kinase.
FT   REPEAT      413    450       HEAT 1.
FT   REPEAT      458    495       HEAT 2.
FT   REPEAT      572    610       HEAT 3.
FT   REPEAT      991   1030       WD 1.
FT   REPEAT     1040   1079       WD 2.
FT   REPEAT     1093   1134       WD 3.
FT   REPEAT     1139   1178       WD 4.
FT   REPEAT     1182   1223       WD 5.
FT   REPEAT     1237   1278       WD 6.
FT   REPEAT     1327   1358       WD 7.
FT   NP_BIND      32     40       ATP (By similarity).
FT   COMPBIAS    781    784       Poly-Glu.
FT   COMPBIAS    974    977       Poly-Pro.
FT   ACT_SITE    148    148       Proton acceptor (By similarity).
FT   BINDING      53     53       ATP (By similarity).
FT   MOD_RES     808    808       Phosphoserine.
FT   MOD_RES     813    813       Phosphoserine.
FT   MOD_RES     814    814       Phosphoserine.
FT   MOD_RES     853    853       Phosphoserine.
FT   MOD_RES     861    861       Phosphoserine.
FT   MOD_RES     865    865       Phosphoserine.
FT   MOD_RES     892    892       Phosphoserine.
FT   MOD_RES     894    894       Phosphoserine (By similarity).
FT   MOD_RES     905    905       Phosphoserine (By similarity).
FT   MOD_RES     925    925       Phosphoserine.
FT   MOD_RES    1079   1079       Phosphoserine.
FT   MOD_RES    1316   1316       Phosphothreonine.
FT   LIPID         2      2       N-myristoyl glycine.
FT   VARIANT     273    273       F -> L (in dbSNP:rs55951445).
FT                                /FTId=VAR_040997.
FT   VARIANT     342    342       R -> H (in dbSNP:rs56295394).
FT                                /FTId=VAR_040998.
FT   VARIANT     347    347       R -> W (in dbSNP:rs34797184).
FT                                /FTId=VAR_040999.
FT   VARIANT     388    388       T -> I (in dbSNP:rs34663155).
FT                                /FTId=VAR_041000.
FT   VARIANT     393    393       D -> N (in dbSNP:rs34633532).
FT                                /FTId=VAR_041001.
FT   VARIANT     699    699       L -> V (in dbSNP:rs56369596).
FT                                /FTId=VAR_041002.
FT   VARIANT     936    936       R -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035632.
FT   VARIANT    1043   1043       G -> V (in dbSNP:rs56160735).
FT                                /FTId=VAR_041003.
FT   CONFLICT    342    343       RI -> EK (in Ref. 1; AA sequence).
FT   CONFLICT    553    554       KQ -> FK (in Ref. 1; AA sequence).
SQ   SEQUENCE   1358 AA;  153103 MW;  5B402175265B21F7 CRC64;
     MGNQLAGIAP SQILSVESYF SDIHDFEYDK SLGSTRFFKV ARAKHREGLV VVKVFAIQDP
     TLPLTSYKQE LEELKIRLNS AQNCLPFQKA SEKASEKAAM LFRQYVRDNL YDRISTRPFL
     NNIEKRWIAF QILTAVDQAH KSGVRHGDIK TENVMVTSWN WVLLTDFASF KPTYLPEDNP
     ADFNYFFDTS RRRTCYIAPE RFVDGGMFAT ELEYMRDPST PLVDLNSNQR TRGELKRAMD
     IFSAGCVIAE LFTEGVPLFD LSQLLAYRNG HFFPEQVLNK IEDHSIRELV TQMIHREPDK
     RLEAEDYLKQ QRGNAFPEIF YTFLQPYMAQ FAKETFLSAD ERILVIRKDL GNIIHNLCGH
     DLPEKAEGEP KENGLVILVS VITSCLQTLK YCDSKLAALE LILHLAPRLS VEILLDRITP
     YLLHFSNDSV PRVRAEALRT LTKVLALVKE VPRNDINIYP EYILPGIAHL AQDDATIVRL
     AYAENIALLA ETALRFLELV QLKNLNMEND PNNEEIDEVT HPNGNYDTEL QALHEMVQQK
     VVTLLSDPEN IVKQTLMENG ITRLCVFFGR QKANDVLLSH MITFLNDKND WHLRGAFFDS
     IVGVAAYVGW QSSSILKPLL QQGLSDAEEF VIVKALYALT CMCQLGLLQK PHVYEFASDI
     APFLCHPNLW IRYGAVGFIT VVARQISTAD VYCKLMPYLD PYITQPIIQI ERKLVLLSVL
     KEPVSRSIFD YALRSKDITS LFRHLHMRQK KRNGSLPDCP PPEDPAIAQL LKKLLSQGMT
     EEEEDKLLAL KDFMMKSNKA KANIVDQSHL HDSSQKGVID LAALGITGRQ VDLVKTKQEP
     DDKRARKHVK QDSNVNEEWK SMFGSLDPPN MPQALPKGSD QEVIQTGKPP RSESSAGICV
     PLSTSSQVPE VTTVQNKKPV IPVLSSTILP STYQIRITTC KTELQQLIQQ KREQCNAERI
     AKQMMENAEW ESKPPPPGWR PKGLLVAHLH EHKSAVNRIR VSDEHSLFAT CSNDGTVKIW
     NSQKMEGKTT TTRSILTYSR IGGRVKTLTF CQGSHYLAIA SDNGAVQLLG IEASKLPKSP
     KIHPLQSRIL DQKEDGCVVD MHHFNSGAQS VLAYATVNGS LVGWDLRSSS NAWTLKHDLK
     SGLITSFAVD IHQCWLCIGT SSGTMACWDM RFQLPISSHC HPSRARIRRL SMHPLYQSWV
     IAAVQGNNEV SMWDMETGDR RFTLWASSAP PLSELQPSPH SVHGIYCSPA DGNPILLTAG
     SDMKIRFWDL AYPERSYVVA GSTSSPSVSY YRKIIEGTEV VQEIQNKQKV GPSDDTPRRG
     PESLPVGHHD IITDVATFQT TQGFIVTASR DGIVKVWK
//
